|
National Stock Number(NSN): 6505-01-145-0510 (6505011450510, 011450510)
| NIIN: |
01-145-0510 |
Item Name: |
CHLORPHENIRAMINE MALEATE AND PHENYLPROPANOLAMINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES |
INC: |
42705
|
| FSC: |
6505
|
Assignment Date: |
Jan-04-1983 |
CRIT: |
N |
IIG: |
42705 |
| ISC: |
5 |
Date Standardized: |
Jan-04-1983 |
HMIC: |
P |
DODIC: |
|
| NSC: |
4 |
Cancellation Date: |
Dec-01-2004 |
PMIC: |
U |
FIIG: |
A510U0 |
| ESD: |
|
Schedule B: |
|
DEMIL: |
A |
DEMIL INT: |
|
| TIIC: |
1 |
Originator: |
97 |
ADPEC: |
|
RPDMRC: |
|
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
NDC00879-0420-01 |
60964
|
HALSEY DRUG CO INC |
H |
3 |
2 |
6 |
54 |
|
|
|
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| AKJA |
ACTIVE MEDICAMENT MEDICINAL STRENGTH |
12.000 MILLIGRAMS CHLORPHENIRAMINE MALEATE ACTIVE INGREDIENT AND 75.000 MILLIGRAMS PHENYLPROPANOLAMINE HYDROCHLORIDE ACTIVE INGREDIENT |
| AKJC |
CAPSULE TYPE |
ANY ACCEPTABLE |
| CQCT |
PRIMARY CONTAINER TYPE |
BOTTLE |
| CQLS |
CAPSULE CONTENT FORM |
ANY ACCEPTABLE |
| CYLZ |
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY |
100.000 |
| FEAT |
SPECIAL FEATURES |
LONG ACTION METHOD:EXTENDED RELEASE; |
| MOE Rule |
Former MOER |
Effective |
AMC |
AMSC |
IMC |
IMCA |
Collaborators |
Receivers |
| G57V |
|
Apr-01-1991 |
0 |
0 |
|
|
54 |
54|57 |
|